- Home
- LXRX vs UROY Comparison
LXRX vs UROY Comparison
Compare LXRX & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- UROY
- Stock Information
- Founded
- LXRX 1995
- UROY 2017
- Country
- LXRX United States
- UROY Canada
- Employees
- LXRX N/A
- UROY N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- UROY
- Sector
- LXRX Health Care
- UROY
- Exchange
- LXRX Nasdaq
- UROY Nasdaq
- Market Cap
- LXRX 124.4M
- UROY 239.1M
- IPO Year
- LXRX 2000
- UROY N/A
- Fundamental
- Price
- LXRX $0.36
- UROY $1.73
- Analyst Decision
- LXRX Buy
- UROY Strong Buy
- Analyst Count
- LXRX 4
- UROY 2
- Target Price
- LXRX $3.67
- UROY $5.60
- AVG Volume (30 Days)
- LXRX 9.5M
- UROY 2.8M
- Earning Date
- LXRX 03-06-2025
- UROY 03-06-2025
- Dividend Yield
- LXRX N/A
- UROY N/A
- EPS Growth
- LXRX N/A
- UROY N/A
- EPS
- LXRX N/A
- UROY N/A
- Revenue
- LXRX $31,081,000.00
- UROY $15,984,827.00
- Revenue This Year
- LXRX N/A
- UROY N/A
- Revenue Next Year
- LXRX $101.91
- UROY $6.55
- P/E Ratio
- LXRX N/A
- UROY N/A
- Revenue Growth
- LXRX 2481.48
- UROY N/A
- 52 Week Low
- LXRX $0.28
- UROY $1.57
- 52 Week High
- LXRX $2.62
- UROY $3.12
- Technical
- Relative Strength Index (RSI)
- LXRX 32.86
- UROY 34.55
- Support Level
- LXRX $0.33
- UROY $1.57
- Resistance Level
- LXRX $0.41
- UROY $1.76
- Average True Range (ATR)
- LXRX 0.06
- UROY 0.13
- MACD
- LXRX -0.02
- UROY -0.02
- Stochastic Oscillator
- LXRX 16.38
- UROY 24.44
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.